Veterinary Medicines

Membrana nasalium comp. PlantaVet

Authorised
  • TUNICA MUCOSA NASI BOVIS GL
  • ECHINACEA PALLIDA E RADICE FERM 33D DIL. D2 (HAB, VS. 33D)
  • ARGENTUM METALLICUM DIL. D29 AQUOS.
Download as PDF

Product identification

Medicine name:
Membrana nasalium comp. PlantaVet
Active substance:
  • TUNICA MUCOSA NASI BOVIS GL
  • ECHINACEA PALLIDA E RADICE FERM 33D DIL. D2 (HAB, VS. 33D)
  • ARGENTUM METALLICUM DIL. D29 AQUOS.
Target species:
  • Dog
  • Cat
  • Rabbit
  • Guinea pig
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • TUNICA MUCOSA NASI BOVIS GL
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • ECHINACEA PALLIDA E RADICE FERM 33D DIL. D2 (HAB, VS. 33D)
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • ARGENTUM METALLICUM DIL. D29 AQUOS.
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
    • Cat
    • Rabbit
      • Meat and offal
        0
        day
    • Guinea pig
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • SaluVet GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Wala-Heilmittel GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 6500348.00.00
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."